Wu FJ, Xu Y, Bao J, Liu X. Non-alcoholic fatty liver disease complicated with autoimmune problems: Analysis of 132 cases.
Shijie Huaren Xiaohua Zazhi 2014;
22:1294-1299. [DOI:
10.11569/wcjd.v22.i9.1294]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To analyze the relationship between non-alcoholic fatty liver disease (NAFLD) and autoimmune diseases.
METHODS: One hundred and thirty-two patients with biopsy-proven NAFLD were divided into four groups: 1 [patients with NAFLD and autoimmune liver disease (AILD)], 2 (patients with NAFLD and autoimmune disease except AILD), 3 (patients with NAFLD and autoimmune phenomena) and 4 (patients with NAFLD alone). All data on clinical and biochemistry indexes, autoantibodies, imaging findings and liver histology were analyzed.
RESULTS: The difference in AST was statistically significant between groups 1 and 4 (P < 0.05). There were significant differences in IgG in groups 1, 2 and 3 compared with group 4 (P < 0.05 for all). Liver stiffness, fibrosis stage and inflammation level were different significantly between group 1 and groups 2, 3 and 4 (P < 0.05 for all).
CONCLUSION: The levels of IgG, liver stiffness, liver fibrosis and hepatic inflammation were correlated with the severity of autoimmune problems. IgG and liver stiffness may act as long-term follow-up indicators.
Collapse